Literature DB >> 125425

Role of serotonin in the discriminative stimulus properties of mescaline.

R G Browne, B T Ho.   

Abstract

Rats were trained to discriminate intraperitoneally administered mescaline from saline in a two-lever operant chamber for food reinforcement. Reward was contingent upon responses made greater than 15 sec apart (DRL-15) on the appropriate lever paired with either drug or saline administration. Following the establishment of discriminative response control by mescaline, the animals were tested for stimulus generalization produced by mescaline after: (a) blockade of periphreral and central serotonin (5-HT) receptors with cinanserin, methysergide, or cyproheptadine; (b) blockade of peripheral 5-HT receptors with xylamidine tosylate; and (c) depletion of brain 5-HT with the tryptophan hydroxylase inhibitor p-chlorophenylalanine (PCPA). The results show that all three central 5-HT antagonists greatly reduced the discriminability of mescaline while the peripheral antagonist, xylamidine tosylate, was without effect. Furthermore, these agents at the doses employed did not effect the discriminability of saline. Depletion of 5-HT with PCPA potentiated the effects of a sub-threshold dose of mescaline and slightly reduced the discriminability of saline. The results indicate that mescaline produces its discriminative stimulus properties by directly stimulating central serotonergic receptors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125425     DOI: 10.1016/0091-3057(75)90052-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Quipazine-induced stimulus control in the rat.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

2.  The stimulus properties of LSD in C57BL/6 mice.

Authors:  J C Winter; A K Kieres; M D Zimmerman; C J Reissig; J R Eckler; T Ullrich; K C Rice; R A Rabin; J B Richards
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

3.  Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Authors:  J C Winter; J R Eckler; K C Rice; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2005-07       Impact factor: 3.533

4.  Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist.

Authors:  D J Minnema; J S Hendry; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.

Authors:  D Fiorella; S Helsley; D S Lorrain; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

6.  Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

Authors:  Jun-Xu Li; Alison Unzeitig; Martin A Javors; Kenner C Rice; Wouter Koek; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2009-08-17       Impact factor: 4.030

7.  Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2008-11-01       Impact factor: 4.530

8.  Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.

Authors:  M Davis
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.

Authors:  P B Silverman; B T Ho
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities.

Authors:  R A Glennon; R Young; J A Rosecrans; M J Kallman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.